PY25406 Introduction to Standards in Pharmaceutical Technology Syllabus:

PY25406 Introduction to Standards in Pharmaceutical Technology Syllabus – Anna University UG Syllabus Regulation 2025

Course Objectives:
• To provide hands-on exposure to pharmaceutical industry practices including manufacturing, quality systems, regulatory compliance, R&D, and industrial management.

Strategic Value of Standards – Scientific significance of pharmacopoeial standards in ensuring identity, strength, quality, and purity of medicines. Role of USP public standards in establishing global quality benchmarks. Economic impact of standards in reducing drug development costs, facilitating generic drug entry, and minimizing information asymmetry in pharmaceutical supply chains. Principles of reference standard management, including characterization, stability, storage conditions, and usage of primary and working standards.
Activities
• Case study discussion on pharmacopeial standards in global pharmaceutical trade. (e.g., ethylene glycol tragedy)
• Identification of reference standard labels and certificates.
• Group discussion on economic benefits of standardization in generic drug development.

Global Pharmacopoeias and Monograph Design – Overview of major pharmacopoeias including Indian Pharmacopoeia (IP), British Pharmacopoeia (BP), United States Pharmacopeia (USP), European Pharmacopoeia (EP), Japanese Pharmacopoeia (JP), and the International Pharmacopoeia. Structure and components of pharmacopoeial monographs, including identification tests, impurity profiling (organic, inorganic, residual solvents), and assay methods. Role of the Pharmacopoeial Discussion Group (PDG) in harmonizing global testing standards.
Activities
• Analysis of a sample drug monograph from IP/USP.
• Comparative study of assay methods a single component drug by UV/HPLC.
• Student presentation on global pharmacopoeial harmonization initiatives.

GxP Compliance – Concept of the GxP framework, including Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP), and Good Distribution Practice (GDP). Role of the Pharmaceutical Inspection Co-operation Scheme (PIC/S) in harmonizing global pharmaceutical inspections. Quality system requirements based on WHO Technical Report Series (TRS) guidelines and ICH Q9 quality risk management. Importance of site master files and inspection readiness.
Activities
• Preparation of a Site Master File outline.
• Simulation exercise on pharmaceutical inspection readiness.
• Group discussion on GMP compliance failures and regulatory actions.

Digital Standards and System Validation – Regulatory requirements for digital compliance, including 21 CFR Part 11 and EU GMP Annex 11. Principles of data integrity (ALCOA+). Validation of computerized systems using the GAMP-5 V-model approach. Conduct of quality audits, identification of non-conformances, and implementation of Corrective and Preventive Actions (CAPA).
Activities
• Case analysis of data integrity violations in pharmaceutical companies.
• Demonstration of ALCOA+ principles in laboratory documentation.
• Audit simulation identifying non-conformances and CAPA planning.

Weightage: Continuous Assessment: 60%, End Semester Examinations: 40%.

Assessment Methodology: Continuous Assessment (40%)
• Quiz / MCQ test on pharmacopoeial standards – 10%
• Assignment / case study analysis – 10%
• Activity-based presentation (monograph/GMP audit simulation) – 10%
• Internal test – 10%
• End Semester Examination (60%)

References
1. Sharma, N., et al. Understanding Pharmaceutical Standards and Regulations. Routledge, 2025.
2. Nally, J. D., & McConnell, M. Good Manufacturing Practices for Pharmaceuticals: A Plan for Total Quality Control. CRC Press.
3. Willig, S. H., Stoker, J. R., & Lyda, R. F. Good Manufacturing Practices for Pharmaceuticals. CRC Press / Informa Healthcare.
4. Williams, D. R., et al. (2018). “The Value of U.S. Pharmacopeial Standards: A Review of the Literature.” Journal of Pharmaceutical Sciences, 107(10).
5. United States Pharmacopeial Convention. United States Pharmacopeia – National Formulary (USP–NF). USP Convention, Rockville, USA.
6. Indian Pharmacopoeia Commission. Indian Pharmacopoeia. Ministry of Health and Family Welfare, Government of India.
7. Segalstad, S. H. International IT Regulations and Compliance. Wiley, 2008.
8. World Health Organization (WHO). WHO Technical Report Series: Expert Committee on Specifications for Pharmaceutical Preparations. WHO Press.

E-Resources
1. United States Pharmacopeia (USP): https://www.usp.org
2. Indian Pharmacopoeia Commission: https://ipc.gov.in
3. European Directorate for the Quality of Medicines (EDQM): https://www.edqm.eu
4. ICH Guidelines (Quality): https://www.ich.org
5. WHO Guidelines on Good Manufacturing Practices:
https://www.who.int/teams/health-product-policy-and-standards/standards-andspecifications